Sample integrityplays a vital role on the quality of results in hemostasis testing

Srinivas Naidu,Senior Product Manager- Coagulation Marketing,Sysmex talks about company’s CN-series which takes the reliability and performance of Sysmex CS-series and takes it up to a whole new level

In haemostasis, test results can point out major clinical issues, some of which may be life-threatening if not dealt with swiftly and accurately. For instance, Cardiovascular Disease (CVD) is one of the leading causes of death and disability in the world. And this is not likely to change any time soon, considering the demographics and lifestyle we see today. Like all patients, people with CVD have the best chance of survival when their illness is detected early.

Labs offering haemostasis testing can really support clinicians with patient diagnosis. Since confidence in the subsequent clinical decision-making is essential, you need equipment that performs reliably and produces results of consistent, high quality at all times. You need to meet TAT demands and help patients as soon as possible, so the tests have to be performed fast –even with complex samples that require precise pre-analytical treatment. And as the industry evolves, the spectrum of test requests is increasing too. It’s a challenging situation.

Unlike other areas of testing the sample integrity plays a vital role on the quality of results in hemostasis testing. So, if an analyzer is able to identify erroneous samples, then that would be an ideal analyzer for a respective laboratory.

Sysmex, a leading global player in hemostasis Instrumentation and Reagents addresses these concerns with their latest analyzer, Sysmex CN- Series.

Sysmex CN-series, takes the reliability and performance of Sysmex CS-series and takes it up to a whole new level.

Sysmex was the first company worldwide to incorporate pre analytical sample testing and Platelet aggregometry testing in a hemostasis analyzer and our commitment remains the same with the CN-Series also which provides all these and much more.

Sysmex CN-Series comes with a higher throughput thereby lessening the turnaround time and even with the higher throughput the space requirement is very low.

The dead volumes of samples are very low so that means there are more analyses from lesser volumes.

Sysmex CN-Series identifies sub-optimal samples by employing HIL (Hemolysed, Icteric and Lipemic) testing and Sample volume check, clot waveform analysis to assess comprehensive hemostasis functions. CN-Series Inhibitor testing more convenient with the Cross-mixing functions.